$1.74
0.0754.52%
Last update: Nov 6, 7:00 AM
Black Diamond Therapeutics Inc
BDTXNASDAQ
Black Diamond Therapeutic (BDTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.21 | $-0.17 | $-0.22 |
| Actual | $-0.17 | $-0.16 | $-0.27 | $-0.15 |
| Surprise | +15.0% | +23.8% | -58.8% | +31.8% |
| Revenue | ||||
| Estimate | $30.0M | $30.0M | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.05 | $-0.21 | $-0.23 | $-0.25 |
| Revenue | ||||
| Consensus | $15.0M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.17 | $-0.20 | 15.0 % |
| Q1 | May 7, 2026 | $-0.16 | $-0.21 | 23.8 % |
| Q4 | Mar 16, 2026 | $-0.27 | $-0.17 | -58.8 % |
| Q3 | Nov 6, 2025 | $-0.15 | $-0.22 | 31.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0 | $30.00M | -100.0 % |
| Q1 | May 7, 2026 | $0 | $30.00M | -100.0 % |
| Q1 | May 12, 2025 | $70.00M | $23.33M | 200.0 % |
